290 related articles for article (PubMed ID: 8262560)
41. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.
Ferrari C; Penna A; Giuberti T; Tong MJ; Ribera E; Fiaccadori F; Chisari FV
J Immunol; 1987 Sep; 139(6):2050-8. PubMed ID: 2957446
[TBL] [Abstract][Full Text] [Related]
42. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen.
Isogawa M; Kakimi K; Kamamoto H; Protzer U; Chisari FV
Virology; 2005 Mar; 333(2):293-300. PubMed ID: 15721363
[TBL] [Abstract][Full Text] [Related]
43. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
Kita H; Moriyama T; Kaneko T; Harase I; Nomura M; Miura H; Nakamura I; Yazaki Y; Imawari M
Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568
[TBL] [Abstract][Full Text] [Related]
44. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.
Rawle FC; Tollefson AE; Wold WS; Gooding LR
J Immunol; 1989 Sep; 143(6):2031-7. PubMed ID: 2789254
[TBL] [Abstract][Full Text] [Related]
45. Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
Koeppen H; Acena M; Drolet A; Rowley DA; Schreiber H
Eur J Immunol; 1993 Nov; 23(11):2770-6. PubMed ID: 8223853
[TBL] [Abstract][Full Text] [Related]
46. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B virus immunopathogenesis.
Chisari FV; Ferrari C
Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
[TBL] [Abstract][Full Text] [Related]
48. Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes.
Maimone MM; Morrison LA; Braciale VL; Braciale TJ
J Immunol; 1986 Dec; 137(11):3639-43. PubMed ID: 3491143
[TBL] [Abstract][Full Text] [Related]
49. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
[TBL] [Abstract][Full Text] [Related]
50. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
Bertoletti A; Ferrari C; Fiaccadori F; Penna A; Margolskee R; Schlicht HJ; Fowler P; Guilhot S; Chisari FV
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10445-9. PubMed ID: 1660137
[TBL] [Abstract][Full Text] [Related]
51. T cell lines reactive with hepatitis B core and E antigens in patients with chronic hepatitis B.
Ishikawa T; Kakumu S; Yoshioka K; Wakita T; Shinagawa T; Ito Y
J Clin Lab Immunol; 1991 Apr; 34(4):151-6. PubMed ID: 1668281
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation.
Koay LB; Feng IC; Sheu MJ; Kuo HT; Lin CY; Chen JJ; Wang SL; Tang LY; Tsai SL
Hum Immunol; 2011 Sep; 72(9):687-98. PubMed ID: 21215784
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines.
Guilhot S; Fowler P; Portillo G; Margolskee RF; Ferrari C; Bertoletti A; Chisari FV
J Virol; 1992 May; 66(5):2670-8. PubMed ID: 1313893
[TBL] [Abstract][Full Text] [Related]
54. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
McLain L; Dimmock NJ
J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
[TBL] [Abstract][Full Text] [Related]
55. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
56. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
57. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
Milich DR; McLachlan A; Moriarty A; Thornton GB
J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
[TBL] [Abstract][Full Text] [Related]
58. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.
Roh S; Lee YK; Ahn BY; Kim K; Moon A
Virus Res; 2001 Jan; 73(1):17-26. PubMed ID: 11163641
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.
Ito Y; Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Koike K
Gastroenterol Jpn; 1993 Oct; 28(5):657-65. PubMed ID: 7693538
[TBL] [Abstract][Full Text] [Related]
60. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
Strassman G; Bach FH
J Immunol; 1984 Oct; 133(4):1705-9. PubMed ID: 6332131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
